Dermatitis: Clinical Trials

15 trials for Dermatitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 terminated. 15 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 415Terminated 15

Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dupilumab De-escalation in Pediatric Atopic Dermatitis
Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose - Atopic Dermatitis
Phase 4TerminatedJohns Hopkins University12024-04-012026-11-03
Tralokinumab for Dupilumab Failures
tralokinumab - Atopic Dermatitis
Phase 4TerminatedPsoriasis Treatment Center of Central New Jersey72023-09-112026-05-22
The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.
ruxolitinib cream - Atopic Dermatitis
Phase 4TerminatedIncyte Corporation472023-03-162025-12-19
Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis
Crisaborole 2%, Vehicle treatment, Accelerometry device for children - Atopic Dermatitis
Phase 4TerminatedBoston University722022-07-262025-03-14
The Healthy Baby Bottoms Study
Diaper care with Theraworx - Diaper Dermatitis
Phase 4TerminatedLinda Fu52020-03-122021-12-17
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
Dupilumab, Placebo - Atopic Dermatitis (AD)
Phase 4TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)722018-07-252021-10-04
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
Crisaborole ointment, 2%, Hydrocortisone butyrate cream, 0.1%, Pimecrolimus cream, 1% - Atopic Dermatitis
Phase 4TerminatedPfizer2372018-04-272022-01-10
Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study
Stoss vitamin D, Daily vitamin D, Stoss placebo - Atopic Dermatitis
Phase 4TerminatedMurdoch Childrens Research Institute132017-10-162025-03-14
A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
Triamcinolone 0.1% - Dermatitis, Atopic
Phase 4TerminatedUniversity of California, San Francisco112014-12-012019-01-24
Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.
Ciclosporin, Alitretinoin - Atopic Dermatitis
Phase 4TerminatedTechnische Universität Dresden152010-11-012014-06-03
Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis
Dapsone gel, 5% - Dermatitis Herpetiformis
Phase 4TerminatedVanderbilt University Medical Center12010-07-012017-12-14
Safety and Efficacy of Quadriderme® in the Treatment of Impetiginous Eczema (Study P05134AM4)
Cream (betamethasone diproprionate, clotrimazole, and gentamicin sulfate), Cream (betamethasone diproprionate and gentamicin), Cream (betamethasone diproprionate) - Dermatitis, Atopic, Eczema, Atopic
Phase 4TerminatedOrganon and Co32009-07-012022-02-09
Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children
pimecrolimus active cream, placebo base cream - Atopic Dermatitis
Phase 4TerminatedChildren's Hospital of Michigan182006-11-012008-12-18
Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis
Penicillin versus cefuroxim per os - Streptococcal Infections
Phase 4TerminatedUniversity Children's Hospital Basel1942005-10-012007-01-17
Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
Pimecrolimus, Corticosteroid - Atopic Dermatitis
Phase 4TerminatedNovartis Pharmaceuticals10912003-10-012011-03-23

Narrower conditions

Dermatitis, Atopic (12)  ·  Asthma (1)  ·  Dermatitis Herpetiformis (1)  ·  Diaper Rash (1)  ·  Mandibulofacial Dysostosis (1)  ·  Pruritus (1)  ·  Skin Diseases, Eczematous (1)  ·  Streptococcal Infections (1)

Broader conditions

Skin Diseases (15)  ·  Skin and Connective Tissue Diseases (15)  ·  Immune System Diseases (13)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (12)  ·  Genetic Diseases, Inborn (12)  ·  Hypersensitivity (12)  ·  Hypersensitivity, Immediate (12)  ·  Skin Diseases, Eczematous (12)  ·  Skin Diseases, Genetic (12)  ·  Autoimmune Diseases (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Developmental (1)

Interventions

pimecrolimus (3)  ·  crisaborole (2)  ·  dupilumab (2)  ·  Adrenal Cortex Hormones (1)  ·  Alitretinoin (1)  ·  Clotrimazole (1)  ·  Cyclosporine (1)  ·  Dapsone (1)  ·  Gels (1)  ·  Gentamicins (1)  ·  Ointments (1)  ·  Triamcinolone (1)  ·  Zinc Oxide (1)  ·  ruxolitinib (1)  ·  tralokinumab (1)

Sponsors

Boston University (1)  ·  Children's Hospital of Michigan (1)  ·  Incyte Corporation (1)  ·  Johns Hopkins University (1)  ·  Linda Fu (1)  ·  Murdoch Childrens Research Institute (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Novartis Pharmaceuticals (1)  ·  Organon and Co (1)  ·  Pfizer (1)  ·  Psoriasis Treatment Center of Central New Jersey (1)  ·  Technische Universität Dresden (1)  ·  University Children's Hospital Basel (1)  ·  University of California, San Francisco (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (10)  ·  Germany (2)  ·  Switzerland (2)  ·  Australia (1)  ·  Italy (1)  ·  Poland (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Joy Wan, MD MSCE (1)  ·  Kevin C Thomas, PhD (1)  ·  Kirsten P Perrett, MBBS (1)  ·  Lisa A. Beck, MD (1)  ·  Sarah Arron, MD, PhD (1)  ·  Ulrich Heininger, MD (1)  ·  Urs B Schaad, MD (1)

Results publications

PMID 16680006, PMID 18385500, PMID 20070141, PMID 22805051, PMID 22920495, PMID 22951056, PMID 23374261, PMID 26598458

NIH funding

2009 (1), 2018 (1), U19AI117673 (1)